Ignite Creation Date:
2025-12-26 @ 2:39 PM
Ignite Modification Date:
2025-12-29 @ 11:38 AM
Study NCT ID:
NCT04393506
Status:
COMPLETED
Last Update Posted:
2023-11-22
First Post:
2020-05-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma
Sponsor:
Shanghai Jiao Tong University School of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-23
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-10
Completion Date Type:
ACTUAL
First Submit Date:
2020-05-03
First Submit QC Date:
None
Study First Post Date:
2020-05-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-21
Last Update Post Date:
2023-11-22
Last Update Post Date Type:
ACTUAL